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Increased dietary fructose in rodents recapitulates many
aspects of the Metabolic Syndrome with hypertension,
insulin resistance and dyslipidemia. Here we show that
fructose increased jejunal NaCl and water absorption which
was significantly decreased in mice whose apical chloride/
base exchanger Slc26a6 (PAT1, CFEX) was knocked out.
Increased dietary fructose intake enhanced expression of this
transporter as well as the fructose-absorbing transporter
Slc2a5 (Glut5) in the small intestine of wild type mice.
Fructose feeding decreased salt excretion by the kidney
and resulted in hypertension, a response almost abolished in
the knockout mice. In parallel studies, a chloride-free diet
blocked fructose-induced hypertension in Sprague Dawley
rats. Serum uric acid remained unchanged in animals on
increased fructose intake with hypertension. We suggest that
fructose-induced hypertension is likely caused by increased
salt absorption by the intestine and kidney and the
transporters Slc26a6 and Slc2a5 are essential in this process.
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Metabolic syndrome, which is manifested by visceral obesity,
hypertension, glucose intolerance, insulin resistance, and
atherogenic dyslipidemia,1–6 is reaching epidemic propor-
tions worldwide, with over 30 million in the United States
alone. Its increased incidence correlates with marked increase
in the amount of dietary fructose consumption from high
fructose corn syrup, a common sweetener used in the food
industry, table sugar, and fruits.1–6 Although the increase in
the incidence of obesity has been attributed to increased
calorie intake and decreased physical activity, the pathogen-
esis of hypertension in metabolic syndrome remains less well
understood.7–11 In rodents, increased dietary fructose intake
for 4–12 weeks recapitulates many aspects of metabolic
syndrome.12–17
SLC26A6 (human)/Slc26a6 (mouse), also known as PAT1
(putative anion transporter 1) or CFEX (chloride/formate
exchanger), is a major apical chloride/base exchanger in the
small intestine and kidney proximal tubule.18–23 PAT1, which
can function in Cl/HCO3
 and Cl/oxalate exchange modes
in vivo,21,24,25 plays an important role in the absorption of
salt and secretion of bicarbonate in the small intestine.24–28
The absorption of fructose in the small intestine and kidney
proximal tubule is thought to be mediated predominantly by
Glut5 (Slc2a5).29,30
Hypertension is a complex, multifactorial disorder and
attributing its etiology to a single factor is probably
simplistic. One major factor, however, which is essential to
the understanding of blood pressure regulation and its
disturbance in hypertension, is altered salt homeostasis.31–35
There are no studies on the role of altered salt absorption in
the intestine or the kidney as a major contributor to
hypertension in metabolic syndrome or, specifically, in
fructose-induced hypertension.
RESULTS
Colocalization of PAT1 and Glut5 on the apical membrane in
the jejunum
Western blot analysis in apical membrane proteins from
jejunum detected Glut5 as a doublet at B55 kDa, with a
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strong upper band and a faint lower band in normal
(Slc26a6þ /þ ) mice (Figure 1a, left panel). PAT1 was detected
as a B90-kDa band in the same membrane proteins (Figure
1a, right panel). Figure 1b is an immunofluorescence labeling
indicating the localization of Glut5 and PAT1 (Slc26a6) on
the apical membrane of villi in the jejunum. Glut5 mediates
the absorption of fructose whereas Slc26a6 is a chloride-
absorbing transporter. Both Glut5 and PAT1 demonstrate
identical distribution pattern along the length of jejunal villi.
The distribution pattern and labeling intensity of Glut5 in
jejuna of Slc26a6/ mice (Figure 1c) was similar to that in
Slc26a6þ /þ mice (Figure 1b).
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Figure 1 | Expression of Glut5 and PAT1 in jejuna of Slc26a6þ /þ
mice. (a) Immunoblot analysis of Glut5 and PAT1 in jejuna of
Slc26a6þ /þ mice. The Glut5 appears as a doublet at B55 kDa,
with the upper band showing enhanced intensity and lower
band showing decreased intensity in mouse jejunum.
(b) Immunofluorescence labeling of Glut5 and Slc26a6þ /þ in
normal mouse jejunum. Both Glut5 and Slc26a6 label the apical
membranes in jejunum villi. (c) Expression of Glut5 in jejunum
of Slc26a6þ /þ (left) and Slc26a6/ mice (right).
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Figure 2 | Effect of fructose on fluid (salt) absorption in
Slc26a6 and Glut5 mutant mice. (a) Basal and fructose-induced
jejunal fluid absorption in Slc26a6þ /þ and Slc26a6/ mice. Basal
rates were reduced by B25% in Slc26a6/ mice as compared
with Slc26a6þ /þ littermates. 40 mM fructose elicited B67%
increase in fluid absorption in Slc26a6þ /þ mice but only
B39% in Slc26a6/ mice. #Po0.01 as compared with NaCl
control. (b) Fructose-induced jejunal fluid absorption in Slc26a6þ /þ
and Slc26a6/ mice. The magnitude of fructose-stimulated fluid
absorption was B110% higher in Slc26a6þ /þ mice as compared
with Slc26a6/ mice. *Po0.05 compared with wild-type control.
Results are mean±s.e.m. (c) The role of chloride ion in basal and
fructose-stimulated fluid absorption. After basal period
measurement in the presence of NaCl, jejunum was perfused with
iso-osmolar chloride-free (150 mM Na gluconate) solution.
Chloride removal inhibited basal fluid absorption by 75%.
Replacement of 40 mM gluconate completely blocked the
fructose-stimulated fluid absorption in normal mouse jejunum.
*Po0.05 compared with NaCl control.
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Fructose stimulates salt absorption in the jejunum
predominantly by activating PAT1
Given the colocalization of Glut5 and PAT-1 on the apical
membrane of jejunum and the fact that PAT1 plays an
important role in salt absorption in this segment,28 we
entertained the possibility that fructose may stimulate salt
absorption by activating Slc26a6. Accordingly, we examined
the effect of fructose on the absorption of salt in the jejunum
in Slc26a6þ /þ and Slc26a6/ mice. Toward this end,
proximal jejunum was perfused in vivo with isotonic
perfusate, and net fluid absorption was examined, before
and after the addition of fructose according to Materials
and Methods.
Figure 2a depicts basal and fructose-induced jejunal fluid
absorption in Slc26a6þ /þ and Slc26a6/ mice. The basal
fluid absorption was reduced byB25% in Slc26a6/ mice as
compared with Slc26a6þ /þ littermates (Po0.05, n¼ 5 in
each group). As shown in Figure 2a, fructose at 40 mM
elicited a B67% increase in fluid absorption in Slc26a6þ /þ
mice (Po0.01, n¼ 5), a response which was significantly
blunted in Slc26a6/ mice. When analyzed, the magnitude
of fructose-stimulated fluid absorption was B110% higher
in Slc26a6þ /þ mice as compared with Slc26a6/ mice
(Po0.05, n¼ 5) (Figure 2b).
The significant reduction in jejuna of Slc26a6/ mice
indicated that the majority of fructose-stimulated fluid
absorption is mediated by Slc26a6, which is the major apical
chloride-absorbing transporter in the upper villus of small
intestine.21,27 In the next series of experiments, we examined
the role of perfusate chloride on fructose-stimulated fluid
absorption. As shown in Figure 2c, the removal of chloride
from the perfusate inhibited the basal fluid absorption by
75% and completely abrogated the fructose-stimulated fluid
absorption in Slc26a6þ /þ mice (*Po0.05 compared with
NaCl control).
Fructose-induced hypertension is dependent on the
presence of PAT1
In the next series of experiments, we examined the effect
of fructose-stimulated, PAT-1-dependent salt absorption in
the small intestine in the generation of fructose-induced
hypertension. First, we observed that increased dietary
fructose intake (60% fructose) for 2 weeks enhances the
expression of Glut5 and PAT1 mRNA (Figure 3a and c), and
protein (Figure 3b and d) in mouse jejunum when compared
with the control diet (60% starch). The mRNA expression
of Glut5 and PAT1 increased by B500% and B240%,
respectively, in mice on increased fructose intake (Po0.001
compared with mice on control diet, n¼ 4). The protein
abundance of Glut5 and PAT1 increased by 150 and 130% in
mice on increased fructose intake (Po0.03 vs mice on
control diet, n¼ 4). The mRNA expression and protein
abundance of NHE3 increased by B80 and B42%,
respectively, in mice on increased fructose intake for 2 weeks
(Figure 3e and f, Po0.05 for both parameters, n¼ 3).
The 2-week time point for expression studies was chosen
based on the fact that animals did not develop hypertension
within this interval of high dietary fructose intake (personal
observation).
We next ascertained the role of Slc26a6 in the pathogenesis
of fructose-induced hypertension by examining Slc26a6þ /þ
and Slc26a6/ mice. Toward this end, mice were subjected
to increased dietary fructose intake (60% fructose) for 12
weeks and compared with mice on control diet (60% starch).
As shown in Figure 4a, Slc26a6þ /þ mice on a high-fructose
diet developed significant increase in their blood pressure
compared with control diet. The systolic blood pressure
in Slc26a6þ /þ mice increased from 102±2 mm Hg on a
normal diet to 111±2.2 mm Hg on a high-fructose diet
(Po0.02, n¼ 5). However, Slc26a6/ mice failed to develop
hypertension on a high-fructose diet (Figure 4a). The blood
pressure in Slc26a6/ mice was 103±2.1 mm Hg on a normal
diet and 106±2 mm Hg on a high-fructose diet (P40.05,
n¼ 5; Figure 4a). The magnitude of fructose-induced blood
pressure elevation was 9±1.3 mm Hg in Slc26a6þ /þ and
3±0.3 mm Hg in Slc26a6/ mice (Po0.001; Figure 4b).
Slc26a6/ displayed normal food intake and weight gain on
control diet or on increased dietary fructose intake relevant to
Slc26a6/ mice. Blood sugar increased in both Slc26a6þ /þ
and Slc26a6/ mice on increased dietary fructose intake
for 12 weeks (Figure 4c). The increase in the concentration
of plasma fructose, measured by HPLC, was comparable in
both Slc26a6þ /þ and Slc26a6/ mice on increased dietary
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Figure 3 | Effect of increased dietary fructose intake on Glut5,
PAT1, and NHE3 expression in the intestine in Slc26a6þ /þ
and Slc26a6/ mice. (a–d) Increased dietary fructose intake
upregulates the expression of Glut5 and Slc26a6 in jejunum. The
expression of Glut5 and Slc26a6 was determined by northern
hybridization (a and b) and western blotting (c and d) at 2 weeks.
The northern blot membrane was first probed for Glut5
expression, and then stripped and reprobed for Slc26a6. (e and f)
The mRNA expression (e) and protein abundance (f) of NHE3 in
jejuna of mice on increased fructose intake for 2 weeks.
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fructose (155±21 and 195±29mmol/100 ml in Slc26a6þ /þ
and Slc26a6/ mice, respectively, P40.05, n¼ 4) or on
control diet (28±3 vs 37±4mmol/100 ml in Slc26a6þ /þ and
Slc26a6/ mice, respectively, P40.05, n¼ 4). These results
indicate that deletion of Slc26a6 did not affect the absorption
of fructose in the intestine.
Fructose-induced hypertension in rat
Sprague–Dawley rats have been extensively used for the
examination of fructose-induced hypertension. In the last
series of experiments, the effect of high-fructose diet on
blood pressure was examined in Sprague–Dawley rats in the
presence or the absence of chloride in the diet, so as to inhibit
the apical chloride/base exchangers in the small intestine.
As shown in Figure 5a, increased dietary fructose intake
for 5 weeks resulted in a significant systolic blood pressure
elevation as compared with the control diet (147±
3.0 mm Hg in control vs 169±3.0 mm Hg in high-fructose
group, Po0.001, n¼ 5). However, the removal of chloride
from the high-fructose diet (chloride free/high fructose)
blocked the fructose-induced hypertension by 70% when
compared with chloride-free alone (138±2 mm Hg in
chloride free vs 145±3 mm Hg in chloride free/high fructose)
and byB100% when compared with the control diet (147±
3 mm Hg in control diet vs 145±3 mm Hg in chloride-free/
high-fructose diet; Figure 5a).
Daily food intake was comparable in all four groups
(18.1±0.6 g in control, 17.5±0.6 g in high-fructose,
16.7±1.0 g in chloride-free, and 17.9±1.4 g in chloride-
free/high-fructose diet; n¼ 5 in each group and P40.05
between all groups). The kidney function parameters,
including serum blood urea nitrogen and creatinine, and
urine osmolarity, remained unchanged in all four groups
indicating that the inhibitory effect of chloride-free diet on
blood pressure elevation was not due to volume depletion
(Figure 5b). Body weights were comparable in rats on the
control, high-fructose, or chloride-free diet and mildly lower
in rats on the chloride-free/high-fructose diet.
Increased fructose intake stimulates salt absorption in the
kidney
The purpose of the next series of experiments was to ascer-
tain the effect of increased dietary fructose intake on chloride
and sodium excretion by the kidney. Accordingly, rats
were placed in metabolic cages and the 24-h urine chloride
and sodium excretion was determined before and after
placement on a high-fructose diet. The results demonstrated
that switching from the control diet to high-fructose diet
significantly decreased the daily excretion of chloride and
sodium by the kidney, an effect that was evident for the 4-day
duration of experiments (Figure 5c). Food intake was
comparable before and after switching to high-fructose diet,
indicating that decreased excretion of sodium and chloride
was not due to decreased salt intake.
The increase in salt absorption in the intestine (Figures 2
and 3) and kidney (Figure 5c) in early stages of increased
dietary fructose intake suggested possible salt overload. To
assess vascular volume status in animals on increased dietary
fructose intake, the expression of renin in the kidney was
examined. The results, depicted in Figure 5d (left panel),
demonstrated that the expression of renin decreased by
B45% in kidneys of animals on increased fructose intake for
2 weeks (Po0.05 vs mice on normal diet, n¼ 3). The
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Figure 4 | High-fructose diet increases blood pressure in
Slc26a6þ /þ but not in Slc26a6/ mice. (a) Systolic blood
pressure was increased significantly in Slc26a6þ /þ mice but
remained unchanged in Slc26a6/ mice on increased dietary
fructose intake for 12 weeks. (b) Fructose-induced blood pressure
increment in Slc26a6þ /þ and Slc26a6/ mice. The increment in
blood pressure elevation by the high-fructose diet was
significantly higher in Slc26a6þ /þ compared with Slc26a6/
mice. (c) High-fructose diet increases blood sugar in both
Slc26a6þ /þ and Slc26a6/ mice. Blood sugar increased
significantly in both Slc26a6þ /þ and Slc26a6/ mice after
12 weeks of increased dietary fructose intake.
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expression of renin in animals on chloride-free/high-fructose
diet remained the same as in animals on chloride-free diet
(Figure 5d, right panel).
Fructose-induced hypertension is not associated with
alterations in serum uric acid
In the next series of experiments, we examined the
plasma uric acid and the 24-h urine uric acid excretion in
rats on increased dietary fructose intake for 5 weeks.
As shown in Figure 6, rats on high-fructose diet for 5 weeks
did not demonstrate any elevation in serum uric acid (3.53±
0.13 mg/100 ml in control and 3.45±0.14 mg/100 ml in
high-fructose group, P40.05, n¼ 5), but showed enhanced
excretion of uric acid in the urine (1.54±0.13 mg/24 h
in control vs 3.78±0.21 mg/24 h in high-fructose group,
Po0.0001, n¼ 5).
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Figure 5 | Effect of dietary chloride intake on fructose-induced hypertension, and blood and urine chemical analysis in rat.
(a) Chloride-free diet blocks fructose-induced hypertension in rats. Systolic blood pressure increased significantly in rats on increased
dietary fructose intake for 5 weeks. The chloride-free/high-fructose diet prevented a rise in blood pressure that was observed in rats on a
high-fructose (normal chloride) diet. (b) Serum and urine chemical analysis in rats on increased fructose intake with or without chloride.
Urine and serum chemistries indicated that the kidney function and vascular volume were normal in rats on the high-fructose, chloride-free,
or chloride-free/high-fructose diet. (c) Daily urinary excretion of chloride and sodium in rats on high-fructose diet. The 24-h urinary excretion
of chloride and sodium reduced significantly in rats on increased fructose dietary intake, when compared with control diet in the same
rats. Animals were in metabolic cages for 5 days, with 1 day on control diet and the following 4 days on increased fructose intake
diet. *Po0.02, **Po0.005, and ***Po0.002 vs control diet. (d) Expression of renin in kidneys of Slc26a6þ /þ mice on increased fructose
intake. Expression of renin decreased byB50% in animals on high-fructose diet for 2 weeks. BUN; blood urea nitrogen.
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Figure 6 | Serum uric acid and urine uric acid excretion in rats
on increased fructose intake. Rats on high-fructose diet for
5 weeks did not demonstrate any elevation in serum uric acid
(a), but showed enhanced excretion of uric acid in the urine (b).
442 Kidney International (2008) 74, 438–447
o r i g i n a l a r t i c l e AK Singh et al.: Molecular mechanism of fructose-induced hypertension
In the last series of experiments, the expression of Glut5
and PAT1 was examined in jejuna of wild-type mice on
control or high-fructose diet for 12 weeks. As shown in
Figure 7 (panels A and B), the expression of Glut5 and PAT1
was increased in mice on increased fructose intake compared
with control diet, with Glut5 expression increasing by
B700% (Po0.001, n¼ 3) and the expression of PAT1
increasing by B55% (Po0.05, n¼ 3), indicating that the
expression of these transporters remains elevated throughout
the experiment. It is worth mentioning that the magnitude of
expression of PAT1 at 12 weeks (Figure 7b) is less than the
increase at 2 weeks of increased dietary fructose intake, which
was at B200% (Figure 3b).
DISCUSSION
The increase in the incidence of metabolic syndrome, which
is reaching an epidemic proportion in developed countries,
correlates with increased dietary fructose intake. The present
studies provide novel insight into the pathogenesis of
fructose-induced hypertension by establishing a strong link
between increased fructose intake and enhanced salt absorp-
tion in the small intestine and kidney tubules.
Unlike the well-studied stimulatory role of glucose on salt
absorption in the intestine, which is mediated predominantly
by the sodium glucose cotransporter (Sglt) and to some
extent the Naþ /Hþ exchanger NHE3,36,37 the role of
fructose on salt absorption remains less well understood,
despite elegant studies over 30 years ago by Fordtran.38 The
current studies confirm such an interaction and delineate the
molecular machinery of fructose-induced salt absorption by
identifying Slc26a6 (PAT1) and Glut5 as integral molecules in
that process.
Slc2a5 (or Glut5) is a high-affinity fructose transporter
whereas Slc26a6 (or PAT1) is a major chloride/base
exchanger. Both are expressed on the apical membranes in
the small intestine and kidney proximal tubule.20,21,29,30
Fructose-stimulated, PAT-1-mediated chloride absorption
(Figure 2) establishes a direct link between increased fructose
intake and enhanced salt absorption in the intestine. In
addition, fructose was shown to increase the absorption of
salt in the kidney tubules (Figure 5c). Taken together, these
results indicate that increased dietary fructose intake causes a
state of salt overload, at least in the early stages of the
experiments, by increasing the absorption of salt in the
intestine and decreasing its excretion by the kidney.
The most salient feature of the present studies is the
prevention of generation of fructose-induced hypertension in
mice lacking Slc26a6 and in rats on a chloride-free diet
(Figures 4 and 5), clearly establishing the role of dietary
chloride and chloride-absorbing transporter Slc26a6 in the
pathogenesis of fructose-induced hypertension. Although
low-salt diet was shown to blunt the magnitude of
hypertension in rats on a high-fructose diet, the molecular
basis of that observation was not delineated.39 The Slc26a6
deletion did not prevent the increase in blood glucose (Figure
4c), clearly indicating that the pathogenesis of hypertension
is distinct from that of blood sugar elevation in animals
on increased fructose intake. These latter results are con-
sistent with comparable fructose absorption in the jejunum
of Slc26a6þ /þ and Slc26a6/ mice, as determined by
14C-fructose absorption (data not shown) and serum fructose
concentration (Results).
The stimulatory effect of fructose on PAT1-mediated
chloride absorption and generation of hypertension are
dependent on Glut5 in the intestinal villi. This conclusion is
supported by our studies demonstrating that acute applica-
tion of fructose to the perfusate in jejunum had no
stimulatory effect on salt absorption in Glut5 null mice
(Stacey Fussell, Sharon Barone, Anurag Kumar Singh,
Hassane Amlal, Fred Lucas, Jie Xu, Xudong Wu, Yiling Yu,
Clifford W Schweinfest, Ursula Seidler, Jian Zuo and
Manoocher Soleimani. The Slc2a5 (Glut5) is absolutely
essential for the absorption of fructose in intestine and
generation of fructose-induced hypertension (manuscript
submitted)). Further, increased dietary fructose intake caused
massive small intestinal malabsorption and severe volume
depletion in Glut5 null mice as early as 72 h after the initiation
of experiments (the above manuscript in preparation).
Increased dietary fructose intake for 2 weeks robustly
increased the expression of Glut5, PAT1, and NHE3 in the
jejunum (Figure 3), consistent with enhanced absorption of
fructose and salt. Taken together, these results demonstrate
two distinct effects of fructose on ion transporters in the
jejunum; the first effect is an acute effect, which is evident
immediately and in a matter minutes following the exposure
to fructose (Figure 2) and is likely independent of a new
protein synthesis. The other effect is observed in response to
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Figure 7 | Expression of Glut5 and PAT1 in the intestine of
Slc26a6þ /þ mice after 12 weeks of increased fructose intake.
Expression of PAT1 and Glut5 increased in the intestine of mice on
high-fructose intake for 12 weeks (panels a and b).
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long-term exposure to high fructose and involves the
synthesis of new proteins for Glut5 and Slc26a6 (Figure 3).
Increased dietary fructose intake decreased the urinary
excretion of salt in the very early stages of experiment
(Figure 5). Coupled with the increased absorption of salt in
the intestine (Figure 2), we propose that increased fructose
intake generates a state of salt overload, at least in the early
stages of increased fructose intake. This assumption is
supported by reduced expression renin in the kidneys of
mice on increased fructose intake for 2 weeks and before the
development of hypertension (Figure 7c). The link between
salt retention and the subsequent generation of hypertension
has been studied. It has been suggested that salt retention can
trigger a cascade of regulatory events that eventually leads to
the release of an endogenous Naþ–Kþ -ATPase inhibitor in
the blood, which, on one hand, enhances the excretion of salt
by decreasing its absorption in the kidney, and, on the other
hand, increases vascular resistance by increasing the intra-
cellular calcium in vascular smooth muscle cells. In support
of this hypothesis, recent studies demonstrated that the
administration of ouabain in mice caused hypertension40 and
that preventing the binding of endogenous ouabain with the
Naþ–Kþ -ATPase blocked the hypertension in various mice
models.41 Our collaborative studies with Dr Bagarov at NIH
demonstrated increased concentration of plasma endogenous
ouabain (Naþ–Kþ -ATPase inhibitor) in animals on high-
fructose diet as early as 5 days after the start of increased
fructose diet (data not shown).
Recent studies demonstrated that SLC26A4 (pendrin),
which is another member of the SLC26 family, can transport
fructose.42 We, therefore, tested the ability of SLC26A6
(human)/Slc26a6 (mouse) to transport 14C-fructose in
cultured COS7 cells and compared the results to Glut5-
mediated fructose absorption. Our results demonstrate that
although Glut5-transfected cells display robust fructose
uptake, the ability of PAT-1-transfected cells to transport
fructose is minimal, both in the presence and the absence of
chloride in the perfusate (Stacey Fussell, Sharon Barone,
Anurag Kumar Singh, Hassane Amlal, Fred Lucas, Jie Xu,
Xudong Wu, Yiling Yu, Clifford W Schweinfest, Ursula
Seidler, Jian Zuo and Manoocher Soleimani. The Slc2a5
(Glut5) is absolutely essential for the absorption of fructose in
intestine and generation of fructose-induced hypertension
(manuscript submitted)). These results indicate that PAT-1
does not play a direct role in fructose absorption in the
intestine. In support of this conclusion, we find that Slc26a6
null mice, unlike Glut5 null mice, have no difficulty with the
absorption of fructose, as determined by normal food intake,
normal body weight gain, increased blood glucose and
fructose concentrations, and the absence of diarrhea on
increased dietary fructose intake.
Serum uric acid concentration remained unchanged in
rats on increased dietary intake for 5 weeks (Figure 6).
Enhanced generation of uric acid in rats on increased
fructose intake results in increased uric acid excretion, thus
maintaining serum uric acid concentrations at normal range
(Figure 6). Given the fact that rats were hypertensive at the
time of serum uric acid measurement (Figure 5), our studies
strongly suggest that serum uric acid alteration does not play
a major role in blood pressure elevation in the early stages of
fructose-induced hypertension. The reports demonstrating
the elevation of serum uric acid in rats on increased dietary
fructose intake were performed after 8–10 weeks of experi-
ments, and revealed decreased uric acid excretion in the
kidney.43 It is plausible that the elevation in serum uric acid
in those studies were in large part secondary to the decline in
the kidney function due to the detrimental effect of sustained
hypertension, which could have decreased the excretion of
uric acid. A closer look at the kidney function in animals on
increased dietary fructose intake for 8 weeks or longer is
warranted.
Several studies have demonstrated the important role of
enhanced salt intake and absorption in the kidney, in the
context of high insulin levels, to the pathophysiology of
hypertension in metabolic syndrome.44–46 Although our studies
did not examine the role of insulin in the generation of fructose-
induced hypertension directly, it is plausible that increased
insulin could increase the absorption of chloride and sodium in
the kidney proximal tubule by activating the sodium- and
chloride-absorbing transporters (NHE3 and PAT1). The near
absence of fructose-induced hypertension in Slc26a6/ mice
strongly suggests that any modulating role of insulin is likely
mediated by Slc26a6 or pathways downstream to it.
The role of increased dietary fructose intake, as a causative
factor in the development of metabolic syndrome and the
hypertension associated with it, is getting recognized. Our
studies strongly suggest that fructose-induced hypertension is
largely generated by enhanced salt absorption in the small
intestine and kidney subsequent to the activation of the
apical chloride/base exchanger PAT1 (Slc26a6) and Slc2a5
(Glut5). Low dietary chloride or inhibitors of PAT1 (or
Glut5) could play important role in the prevention of
hypertension and subsequent kidney damage in fructose-
induced hypertension.
MATERIALS AND METHODS
Animals
All studies were approved by the Animal Care Committees at the
University of Cincinnati in Cincinnati (OH, USA) and Hannover
Medical School (Hannover, Germany). Experiments were performed
using Slc26a6/ and Slc26a6þ /þ mice on a C57/B6 background
and in Sprague–Dawley rats. Care was taken to use equal numbers of
male and female mice pairs. Mice were 3–5 months of age. The
genotype of Slc26a6 (Slc26a6/) knockout mice was verified by
PCR as described.21 Animals were housed in standard animal care
rooms with a 12-hour light–dark cycle and were allowed free access
to food and water.
RNA isolation and northern blot hybridization
Total cellular RNA was extracted from intestines of mice or rats on a
high-fructose diet according to established methods,47 quantitated
spectrophotometrically, and stored at 801C. Total RNA samples
(30mg/lane) were fractionated on a 1.2% agarose–formaldehyde gel,
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transferred to Magna NT nylon membranes, cross-linked by
UV light, and baked. Hybridization was performed according to
Church and Gilbert.48 The membranes were washed, blotted dry,
and exposed to a Phosphor Imager screen (Molecular Dynamics,
Sunnyvale, CA, USA). A DNA fragment encompassing mouse
Slc26a6 (nucleotides 445–3038) or Glut5 (nucleotides 78–1062) was
used for northern hybridization. Hybridizations were performed on
separate samples from three or four different animals.
Immunofluorescence labeling
Animals were killed with an overdose of sodium pentobarbital and
perfused through the left ventricle with 0.9% saline followed by cold
4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4).
Jejuna and kidneys were removed, cut in tissue blocks, and fixed in
formaldehyde solution overnight at 41C. Single immunofluores-
cence labeling was performed as described.20,21 Primary antibodies
were polyclonal Slc26a6 antibodies (at 1/30 dilution)21 and
monoclonal Glut5 antibodies from Alpha Diagnostics (San Antonio,
TX, USA) (at 1/80 dilution) that were mixed in 0.3% Triton X-
100–phosphate-buffered saline solution and applied to sections
overnight at room temperature.20,21 Alexa Fluor 488 (green) or
Alexa Fluor 568 (red) goat or mouse antibodies were used as
secondary antibodies. Only slides processed at the same time with
the same concentrations of primary and secondary antibodies
applied under identical protocols were compared. Acquisition
parameters were kept constant between the experimental groups
to allow for comparisons of the intensity of fluorescent labeling.
Immunoblot analysis of Glut5, PAT1, and NHE3
Apical membrane proteins were isolated from jejunal scrapings from
mice or rats.21,49 Proteins were resolved by SDS-polyacrylamide gel
electrophoresis (40mg/lane) and transferred to nitrocellulose mem-
brane. The membrane was blocked with 5% milk proteins, and then
incubated for 6 h with antibodies against Slc26a6 (PAT1), Glut5, or
NHE3. The secondary antibody was a donkey anti-rabbit IgG
conjugated to horseradish peroxidase (Pierce, Rockford, IL, USA).
The results were visualized using chemiluminescence method (Super-
Signal Substrate; Pierce) and captured on light-sensitive imaging film
(Kodak, Rochester, NY, USA). The abundance of Slc26a6, Glut5, or
NHE3 in various experimental groups was quantitated as fold change
compared with control after adjustment for protein loading, as
detected by blotting with b-actin antibody on the same membrane.
NHE3 antibodies were purchased from Alpha Diagnostics.
Transient transfection of Glut5 and PAT1 in cultured cells
Cultured COS7 cells were transiently transfected with mouse PAT1
or Glut5 cDNA. Full-length mouse PAT1 cDNA (GenBank accession
number NM_134420) and Glut5 cDNA (GenBank accession
number NM_019741) were amplified from RNA isolated from
small intestine by reverse transcription-PCR using specific primers
and subcloned into mammalian expression vectors. 14C-fructose
uptake, at 10 min, was assayed at 48 h in cells transfected with the
PAT1 or Glut5 cDNA and compared with sham-transfected cells
according to established methods.
Surgical procedure
Animals (Slc26a6þ /þ , Slc26a6/, Glut5þ /þ , and Glut5/ mice)
were fasted overnight before the experiment. Induction of anesthesia
was achieved by administration of 10ml/g i.p. haloperidol/midazolam/
fentanyl cocktail (haloperidol 12.5 mg/kg, fentanyl 0.325 mg/kg,
and midazolam 5 mg/kg body weight). Abdomen was opened by
one small central incision, and approximately 10–15 cm of the
jejunum was used for measurement. A small polyethylene tube
(PE100) with a distal flange was advanced into the jejunum (3–4 cm
away from stomach), and secured by a ligature that served as an
inlet tube. PE200 flanged tubing was secured by ligature to allow for
drainage. The 10–15-cm isolated jejunum segment with an intact
blood supply was gently flushed and then perfused (Perfusor
compact; BRAUN, Bethlehem, PA, USA) at a rate of 3 ml/h with
150 mmol/l NaCl. Effluents from the isolated segment were visually
free of blood throughout all experiments. Animals were maintained at
371C using a heating pad controlled by a rectal thermistor probe.
Anesthesia was maintained using the cocktail at 20% of the initial
dose every 30–45 min as indicated by respiratory rate and toe
pinch reflex. In both Slc26a6/ and Slc26a6þ /þ animals, the effects
of 40 mM fructose on fluid absorption was evaluated. The effect
of chloride removal from the perfusate on fluid absorption was
examined by using 150 mM Na gluconate. After an initial 30-min
washout and recovery period, basal fluid absorption was measured for
30 min. To examine the effect of luminal fructose, the jejunal segment
was perfused with isotonic solution NaClþ fructose (130 mM
NaClþ 40 mM fructose) or NaCl alone (150 mM NaCl) as control.
At the end of the experiments, mice were killed by cervical dislocation
and length of jejunum was measured.
Measurement of fluid absorption in the jejunum
Slc26a6þ /þ , Slc26a6/, Glut5þ /þ , and Glut5/ mice were used.
The perfusate was collected in a preweighed 4.5-ml collecting tube.
After a 30-min period, the tube was weighed again and the difference
of the two up to four places of decimal was taken as the amount of
fluid recovered after 30 min (taking density of fluid roughly at about
1 g/ml). The difference was further subtracted from 1.5 mm, which was
the original volume recovered after 30 min in case of no fluid
absorption. All values were represented in milliliters of fluid absorbed
per centimeter jejunum length per hour (ml/cm/h).
High-fructose diet
Slc26a6þ /þ and Slc26a6/ mice were placed on a high-fructose
(60% fructose) or control diet (60% starch) for 12 weeks, according
to published reports. In parallel studies, rats were placed on a
regular (60% starch), high-fructose (60% fructose), chloride-free
(chloride replaced by bicarbonate), or chloride-free/high-fructose
diet prepared by Harlan Teklad (Madison, WI, USA) for up to
5 weeks.
Metabolic studies in animals on increased dietary fructose
intake
Rats and wild-type mice were placed in metabolic cages. After
acclimatization to the cage environment, animals (n¼ 5) were
placed on control diet and after 48 h were switched to a high-
fructose diet. Daily urine output was collected and assayed for the
excretion of sodium and chloride. Urine sodium and chloride
concentrations were assayed as described.21 Blood chemical analysis,
including kidney profile function (blood urea nitrogen, serum
creatinine, and urine osmolarity) was performed as described.21
Blood pressure monitoring
Systolic blood pressure in conscious rats was determined using a
tail-cuff sphygmomanometer (Visitech BP2000; Visitech Systems,
Apex, NC, USA). Systolic blood pressure in conscious mice was
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measured by a tail-cuff sphygmomanometer using a BP-2000
(Visitech Systems). Measurements for each rat or mouse represent
mean value of three consecutive recordings performed in the last
week of experiments. All experimental animals were preconditioned
for blood pressure measurements 2 weeks (rats) or 6 weeks (mice)
before euthanasia.
Statistical analysis
Descriptive statistics were expressed as means±s.e.m., with the
number of experiments given in parentheses. The statistical analyses
were performed using Student’s t-test for unpaired data and analysis
of variance, and Fisher’s protected least significant difference for
paired data. Results were considered significant at Po0.05.
Materials
[32P]dCTP and 36Cl were purchased from Perkin-Elmer Life
Sciences, Shelton, CT, USA. 14C-fructose was purchased from
Amersham Biosciences (Piscataway, NJ, USA). Nitrocellulose filters
and other chemicals were purchased from Sigma, St Louis, MO,
USA. The RadPrime DNA labeling kit was purchased from
Invitrogen, Carlsbad, CA, USA.
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